Medidata Solutions Inc (NASDAQ:MDSO) Shares Bought by Legal & General Group Plc

Legal & General Group Plc lifted its stake in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 7.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 61,664 shares of the company’s stock after acquiring an additional 4,077 shares during the period. Legal & General Group Plc owned approximately 0.10% of Medidata Solutions worth $4,158,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Benjamin F. Edwards & Company Inc. lifted its stake in Medidata Solutions by 127.2% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 945 shares of the company’s stock worth $64,000 after purchasing an additional 529 shares during the last quarter. Bronfman E.L. Rothschild L.P. increased its position in shares of Medidata Solutions by 26.9% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 1,286 shares of the company’s stock valued at $87,000 after acquiring an additional 273 shares during the period. Oppenheimer Asset Management Inc. purchased a new position in shares of Medidata Solutions in the fourth quarter valued at about $90,000. Whittier Trust Co. of Nevada Inc. increased its position in shares of Medidata Solutions by 1,068.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 2,558 shares of the company’s stock valued at $172,000 after acquiring an additional 2,339 shares during the period. Finally, Advisor Group Inc. increased its position in shares of Medidata Solutions by 27.1% in the fourth quarter. Advisor Group Inc. now owns 2,553 shares of the company’s stock valued at $173,000 after acquiring an additional 545 shares during the period.

MDSO has been the topic of a number of analyst reports. Piper Jaffray Companies decreased their price objective on shares of Medidata Solutions to $83.00 and set an “overweight” rating on the stock in a research report on Friday, January 4th. BidaskClub cut shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Monday, January 7th. Finally, Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Tuesday, January 8th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $84.60.

Shares of NASDAQ MDSO traded up $1.49 during midday trading on Friday, hitting $93.97. 734,058 shares of the company traded hands, compared to its average volume of 657,805. Medidata Solutions Inc has a 12-month low of $60.10 and a 12-month high of $98.60. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.57 and a quick ratio of 2.71. The stock has a market capitalization of $5.85 billion, a P/E ratio of 97.89, a P/E/G ratio of 6.40 and a beta of 1.42.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.33. Medidata Solutions had a net margin of 7.99% and a return on equity of 9.28%. The company had revenue of $173.50 million for the quarter, compared to analysts’ expectations of $172.12 million. During the same quarter in the previous year, the company earned $0.40 earnings per share. Medidata Solutions’s quarterly revenue was up 16.3% on a year-over-year basis. Research analysts anticipate that Medidata Solutions Inc will post 0.8 earnings per share for the current year.

In related news, EVP Daniel Patrick Shannon sold 19,725 shares of the business’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $75.17, for a total transaction of $1,482,728.25. Following the transaction, the executive vice president now owns 70,497 shares in the company, valued at $5,299,259.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Rouven Bergmann sold 12,512 shares of the company’s stock in a transaction dated Wednesday, February 6th. The stock was sold at an average price of $75.00, for a total transaction of $938,400.00. The disclosure for this sale can be found here. Insiders have sold 47,237 shares of company stock worth $3,568,628 in the last quarter. 4.70% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: This news story was reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.baseballdailydigest.com/news/2019/05/04/medidata-solutions-inc-mdso-shares-bought-by-legal-general-group-plc.html.

Medidata Solutions Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Recommended Story: How to execute a trade ex-dividend strategy?

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.